From 2023 to 2028, the forecast indicates a consistent and gradual decline in the number of confirmed RR-/MDR-TB cases in the UK. The data reveals a steady decrease at a rate of approximately 2% year-on-year. In 2023, actual cases were recorded at 52. The compound annual growth rate (CAGR) reflects a negative growth, indicating an average annual decrease in cases over the five-year period.

Future trends to watch for include:

The impact of improved diagnostic and treatment methods on reducing RR-/MDR-TB cases.
Potential fluctuations in the trend due to changes in public health policies or TB management practices.
The influence of global health initiatives targeting tuberculosis and antibiotic resistance.